Related Experiment Video
Updated: Sep 6, 2025
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.4K
Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.
Caroline Bayart1, Angélique Mularoni2, Nada Hemmani2
1Analytical Sciences, Sanofi, 31/33 Quai Armand Barbès, 69250 Neuville-sur-Saône, France.
Pharmaceuticals (Basel, Switzerland)
|June 24, 2022
Summary
Tetanus toxin fragment C (TTFC) is a safe and effective alternative to tetanus toxoid (TTd) in vaccines. This review details TTFC
Area of Science:
- Biochemistry
- Immunology
- Neuroscience
Background:
- Tetanus toxoid (TTd) is crucial in pharmaceutical vaccines.
- There is a growing demand for safer, well-defined drugs in drug discovery.
- Tetanus toxin fragment C (TTFC) is recognized for neuroprotective and vaccine carrier potential.
Purpose of the Study:
- To systematically review the structural features, properties, and production methods of TTFC.
- To explore the diverse applications of TTFC in drug discovery.
- To evaluate TTFC as a potential alternative to TTd.
Main Methods:
- Systematic literature review.
- Analysis of structural and functional properties of TTFC.
- Compilation of TTFC production methodologies.
- Review of TTFC applications in drug discovery and vaccine development.
Main Results:
- TTFC is derived from tetanus toxin, retaining immunogenicity without toxicity.
- The complete structure of TTFC is well-characterized.
- TTFC exhibits neuroprotective properties for central nervous system disorders.
- TTFC demonstrates broad utility as a carrier, delivery vector, conjugate, booster, and inducer.
Conclusions:
- TTFC presents a well-defined and safer alternative to TTd.
- TTFC offers versatile applications in pharmaceutical research and vaccine development.
- The neuroprotective and immunogenic attributes of TTFC make it a valuable biomolecule.
